Stable factor IX expression and sustained reductions in factor IX use 9 years after gene therapy with CSL220 in adults with haemophilia B

Feb 6, 2026 — 09:15 am - 9:24 AM
The Auditorium

Main session
Presenter:
Wolfgang MIESBACH